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American agriculture has enjoyed momentous success over the past 50 years as measured by the quantity, quality, variety and cost of food and 
fiber. In the years proceeding World War II, the U.S. agricultural sector has 
experienced a significantly high rate of growth in productivity—a level more 
than three times the magnitude of the nonfarm industrial sector.
Into this agricultural system with all its strengths, complexities and chal-
lenges—both biological and political—comes biotechnology. Because of its 
importance to increased competitiveness in today’s expanding global econ-
omy, biotechnology is viewed as one of the keys to U.S. agriculture’s contin-
ued success in the years ahead. Moreover, it is predicted that the world’s 
population will increase at a rate of approximately 90 million people annu-
ally. At this rate, the current global population of just over five billion is ex-
pected to double during the next century. World hunger and malnutrition 
will not be simply problems of inequitable distribution. Expanded food pro-
duction will be essential to accommodate the nutritional needs of this rapidly 
growing global population. Herein lies one of biotechnology’s most pressing 
demands.
A N  I N D U S T R Y  C O M E S  O F  A G E
After years of speculation and commitment, agricultural biotechnology is 
moving slowly from the research laboratory to the barn, the field and the pro-
cessing plant. The puissance of agro-food biotechnology is no longer fantasy. 
Already, diagnosis of disease using biotechnology tools is a reality which is
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changing the face of both human and animal medicine. We are now in what 
some call the age of biology, moving from the age of chemistry.
The U.S. has maintained its preeminence in biotechnology, bolstered 
by strong research programs and well-established foundations in pharma-
ceuticals and agricultural science. For instance, in 1991, sales from biotech-
nologies totaled approximately $5.8 billion, an 18 percent increase over 1990, 
with net exports exceeding $600 million (Burrill and Lee, 1991; Raines, 1991). 
Furthermore, the Council on Competitiveness in the Office of the Vice Presi-
dent (1991) projects that by the year 2000, biotechnology will be a $50 billion 
industry. Currently, private industry spends approximately $2.1 billion an-
nually on technology development (Office of Technology Assessment, 1991a). 
The federal-state agricultural research system spends roughly $1.9 billion 
annually on agro-food biotechnology research and development (Office of 
Technology Assessment, 1991c).
These figures merely underscore the fact that what scientists have come 
to understand thus far about plants and animals is impressive. Moreover, this 
basic knowledge has been rapidly carried forward by a whole host of viable 
applications.
I M P A C T  O F  B I O T E C H N O L O G Y  O N  A N I M A L  A G R I C U L T U R E
Over the next 15 years, American farmers and ranchers will be offered an ex-
tensive array of new technologies that could revolutionize food animal pro-
duction. Ongoing research in the areas of computers, information systems 
and processing, robotics, controlled environments and biotechnology are ex-
pected to provide numerous on-farm practical applications (National Re-
search Council, 1990). Such technologies point to more efficient growth rates, 
less feed per unit of output, improved disease resistance and increased pro-
lificacy (Van der Wal et al., 1991).
Today, biotechnology has provided animal agriculture with safer, more 
efficacious vaccines against viral and bacterial diseases such as pseudorabies, 
enteric colibacillosis, and foot-and-mouth disease. We are beginning to seek 
answers to questions regarding complex systems that only a few years ago we 
could not even think to ask. This increased ability is particularly important 
in light of the fact that food animal products account for approximately one- 
half of all U.S. agricultural revenues on an annual basis. Producing leaner, high 
quality meat and meat products to satisfy today’s health-conscience consumer is 
of paramount importance (Pearson and Dutson, 1990; Kopchick, 1992).
Further, the first few commercialized on-farm animal biotechnology 
products will be of particular significance since: 1. they will heavily influence 
public attitudes about other emerging products and applications; 2. will es-
tablish substantive and procedural precedents in the legislative and regula-
tory arenas; and 3. will impact the future willingness of the corporate com-
munity to invest in like or similar product research and development (Kalter, 
1985; National Research Council, 1987; Office of Technology Assessment, 1991 d).
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Unfortunately, there is a lack of recognition in some circles that biotech-
nological applications complement, rather than replace, the traditional 
methods used to enhance agricultural productivity. In reality, many of the 
so-called “new” biotechnologies involve concepts based on centuries-old ap-
plications (Moses and Cape, 1991). Bovine somatotropin (BST) is an inter-
esting example—a product that elaborates familiar disciplines such as breed-
ing, animal nutrition, animal physiology and veterinary science, supple-
mented with the basic disciplines of molecular genetics, biochemistry, micro-
biology and bioprocess engineering (Office of Technology Assessment, 1991 d).
C U R R E N T  C H A L L E N G E S  F A C I N G  A N I M A L  A G R I C U L T U R E
Meeting the challenges of international competitiveness, sustaining a high 
quality food supply, preserving natural resources and protecting the environ-
ment will require a heightened level of knowledge over and above what was 
required to solve previous problems of years past (National Research Coun-
cil, 1989). In fact, an array of thought-provoking questions are being posed 
from both within and outside the agricultural sector. For example, how can 
the safety of biotechnologies, which may be used in food production or pro-
cessing, be systematically evaluated? Will the release of genetically modified 
organisms into the environment pose threats to human health or to natural 
ecosystems? Is new legislation necessary to regulate the agro-food and fiber 
products that are likely to be developed utilizing biotechnologies? These and 
other intricate questions are being voiced with a heightened urgency.
Clearly, the issues and strategies have become increasingly complex. 
Legislative authority and jurisdiction have become widely dispersed among 
several congressional committees and subcommittees with differing and like 
perspectives. Nonetheless, in the end, an effective biotechnology policy must 
knit several dimensions into a coherent framework—including basic re-
search, development and application, marketing and economic competitive-
ness, effective regulation, ethics and public policy (Office of Technology As-
sessment, 1991a).
O V E R C O M I N G  O B S T A C L E S  T O  C H A N G E
Worldwide, biotechnology is debated on three fundamental planes. The risks 
and benefits are disputed on scientific grounds, socioeconomic grounds and 
on the basis of public perception (von Oehsen, 1988; Wald, 1992). As with 
any other new technology, many questions of adjustment to change are posed. 
Concern about the effects of technological change has been a constant in the 
history of industrial development. But how should a democratic society es-
tablish public policies on advanced technical issues like biotechnology?
The primary difficulties inhibiting adoption would appear to lie in the 
provinces of administration, economics, management—and politics. The 
political debate surrounding biotechnology begins at the edge of scientific
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knowledge and lies in the realm of “What if?” Consequently, the barriers are 
both technical and institutional (Ruttan, 1991). Although we live in a society 
where the words of acknowledged experts are often received as gospel, our 
fascination with authority shows some indication of waning. Scientists, in-
dustrialists, politicians and educators have been found to be as fallible as 
other human beings and their “expert” information is greeted with skepticism 
by some, and with open defiance by others.
Today, the agricultural research community, and production agriculture 
in general, face several formidable outside forces. Such influences are fre-
quently referred to as externalities which can either have a positive or nega-
tive effect upon agricultural research and its use—particularly for agro-food 
biotechnology. The ultimate judge of emerging technologies will be the con-
sumer-—whether that be the farmer, homemaker or general public 
(Harlander, 1991). It is they who will appraise the merits of a particular 
product or process and determine its success or failure.
U N D E R S T A N D I N G  C O N S U M E R  C O N C E R N S
Within the past few years the popular press has captured the public’s atten-
tion with the perceived role biotechnology might play in agriculture, citing 
both positive and negative aspects, whether realistic or wildly speculative. 
Further, many of the terms used in current discussions of biotechnology have 
negative overtones. For example, words such as “genetic manipulation” and 
“genetic engineering” have a pernicious ring to the general public, and it is 
significant that those campaigning against BST continually refer to the prod-
uct as “bovine growth hormone.”
Part of the problem surrounding the broad acceptance of biotechnology 
stems from the frequently espoused concern that the processes of scientific 
research, and the applications derived therefrom, seem difficult to access and 
thus opaque, especially to the ordinary citizen. An examination of the testi-
mony received by the U.S. House Committee on Agriculture over the last several 
years would seem to indicate that concerns regarding biotechnology and other 
advancements facing animal agriculture fall into two broad categories—those 
relating to animal and consumer safety issues and those relating to social and 
ethical issues. Furthermore, the testimony submitted by various public inter-
est groups can be summarized under four question headings: 1. Is it natural?
2. Is it right? 3. Is it fair? and 4. Do we need it?
Many characteristics have been identified in the literature that appear to 
influence consumer acceptance of innovation. Among them are relative ad-
vantage, compatibility, complexity, trialability, observability—and risk 
(Herbig and Day, 1992).
Undoubtedly, citizens in the U.S. and around the world are going 
through an often mind-numbing debate about risk and reward in many as-
pects of their lives. Whether it is food safety, car safety, atomic energy, liabil-
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ity laws or even nuclear weapon proliferation, we are in the midst of a debate 
about the “balance” of risk and reward in society. Public attitudes can vary, 
often for reasons beyond the influence of more or better information about 
potential personal, environmental or socioeconomic consequences of a tech-
nology. Moreover, some people may react negatively to the perceived impacts 
associated with anything new or innovative.
What happens if the consumer does not change and refuses to use a tech-
nology? Should one blindly accept the scientists’ opinion of what is best? Do 
the vested interests which exist in a company or industry for an innovation 
mean that consumers must accept their decision? There are a whole host of 
questions and public concerns which must be properly considered and ad-
equately addressed if we are to clearly see what the perspectives are for intro-
ducing biotechnology in farm animal production. The creation and mainte-
nance of the public trust is surely one of the pivotal tasks to be undertaken 
(Harlander, 1991; Stenholm and Waggoner, 1992).
T H E  N E E D  T O  C O M M U N I C A T E
There are those who ask, “Why do we need to understand the consumer’s ac-
ceptance mechanism?” The answer is simple and straightforward: If scientific 
advances are to be allowed to provide an affordable, nutritious and sustain-
ing diet for all, the information gap between science and the lay public must 
be narrowed and the consumer’s perspective understood. Once the public is 
knowledgeable and properly informed, the word “biotechnology” in connec-
tion with food production should not raise a red flag of fear, but rather pre-
sent thoughts of reduced food costs, more nutritious food supplies, a safer 
food supply and a healthier environment in which to raise one’s family.
In an effort to foster the public trust, greater efforts are needed in pro-
viding useful information about the working areas of biotechnology and its 
applications in animal production (Office of Technology Assessment, 199 Id; 
Moses and Cape, 1991). Such information could help support an open and 
balanced public debate, and thus, form a firmer basis for sound decision-
making and sufficient monitoring. We must ensure that our systems of over-
sight, legislative and regulatory, are transparent and open to full participa-
tion by all responsible parties (Stenholm and Waggoner, 1992). At a time 
when more and more of American life is rooted in science and technology 
and when the nation’s economic well-being depends as never before on its 
understanding and utilization, the federal government cannot be complacent 
about the public’s interest and confidence in science. Of course, there will al-
ways be some degree of risk, but as understanding grows the circle of consen-
sus will widen.
A sure prescription for disaster is for each of the many sides of the dis-
cussion to treat the others with contempt. Sincere understanding of the ob-
structions, and a mutual willingness to confront them, is a critical first step 
toward positive conflict resolution.
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F L E X I B I L I T Y  I S  T H E  K E Y
A competitive and profitable agriculture will depend on flexibility—on the 
industry’s ability to respond to, and operate within, an uncertain and rapidly 
changing environment. This means we must learn to view agriculture as a 
system. We cannot be “smart in the parts” and “dumb in the whole.”
Today’s current federal meat inspection scheme is a useful example where 
flexibility and science-driven decisions are presently in short supply. After vis-
iting numerous modern meat processing facilities operating all across 
America, one should recognize that meat hygiene is a complex subject involv-
ing aspects of animal husbandry and physiology as well as food technology 
and microbiology. Growing scientific consensus supports the view that the 
allocation of inspection resources in modern meat and poultry production 
and processing enterprises should reflect a distribution according to risk 
rather than a distribution according to the classical rules of meat inspection 
which rely heavily upon human organoleptic methods of detection (General 
Accounting Office, 1992). Unfortunately, resistance from the inspector’s labor 
union and ongoing concerns within consumer advocacy groups has so far pre-
vented the full implementation of a truly science-based, risk-oriented scheme.
In protecting the public health, a stable and sound regulatory regime is 
essential. However, since the agro-food industries experience rapid break-
throughs in the discovery of new techniques and products, it is important 
to ensure that regulatory systems do not lag behind emerging, proven devel-
opments (Office of Technology Assessment, 1988; Council on Competitive-
ness, 1991).
The key to improved competitiveness will lie in a relatively more flexible 
industrial structure and social organization capable of quickly taking advan-
tage of new technological advances (Office of Technology Assessment, 1991b). 
Further, industry should not rely on the regulatory process as the only mech-
anism to influence public opinion. The biotechnology and food industries 
need to strengthen and promote their own credibility to reduce the burden 
on, and necessity of, the review and inspection processes.
T H E  I N T E R N A T I O N A L  D I M E N S I O N
Biotechnology knows no international boundaries. A number of nations have 
targeted biotechnology as being critical for future economic growth—giving 
rise to several nationally based research and development programs (Office 
of Technology Assessment, 1991a). As a result, agricultural systems through-
out the world continue to adopt new and advanced technologies that enable 
them to become more efficient and competitive in developing new markets 
and capturing old markets for their agricultural products (National Research 
Council, 1987). The Japanese government, in particular, has organized re-
search consortia among companies, has sponsored research into biotechnol-
ogy by industry, and has greatly enlarged its overall funding of biotechnology
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research (Yuan and Dibner, 1990). Consequently, the speed in which innova-
tions are adapted to commercial purposes is a critical factor in achieving and 
maintaining America’s own international competitiveness.
In many critical, high-technology sectors such as biotechnology, Ameri-
can firms are facing competitors whose business risks are shared by their gov-
ernments (Office of Technology Assessment, 1991b). The U.S. approach to 
promoting particular industries has been one of refrain and “hands-off,” the 
underlying belief being that the national economic interest is best served by 
free and fair competition in the marketplace—at home and abroad. Does this 
approach still make sense in a world where governments in most advanced in-
dustrial nations, including those of our most able competitors, are cooperat-
ing with private business to promote critically important industries? Main-
taining the productivity and competitiveness of U.S. agriculture in the public 
interest requires a proper balance between public and private sector support 
for technological change. To move agriculture toward new market opportu-
nities, government must not only support worthy research endeavors, it must 
also be a partner with industry in moving promising ideas and applications 
from the lab to the farm (National Research Council, 1989). Further, in such 
a research-intensive industry, the need to protect innovation is crucial. Many 
researchers and industry leaders cite protection of intellectual property as 
being of paramount importance to preserving competitiveness in biotech-
nology (Office of Technology Assessment, 1991a).
Patenting, licensing and regulatory issues are all areas that affect the rate 
and cost of technology transfer. They play necessary roles in advancing tech-
nology transfer and facilitating the commercialization of research results, es-
pecially in capital-intensive fields such as biotechnology. Consequently, ef-
forts should be continued to harmonize and improve intellectual property 
protection procedures throughout the world (Office of Technology Assess-
ment, 1989; Council on Competitiveness, 1991).
M A R K E T  S T R A T E G Y  E S S E N T I A L S
Will the United States retain its preeminence in biotechnology or will prod-
ucts and services derived from biotechnology be more successfully commer-
cialized in other nations? Acceptance of a new agricultural product seems 
deceptively simple. Our most superficial experiences tell us that good ideas 
should work and fittingly render a tidy profit to the innovator. However, all 
too often the marketing mechanism employed is not marketing pull, but 
technological push (Herbig and Day, 1992). Marketers often presume that 
since the technology exists and an innovation has been created, its diffusion 
is inevitable—a fait accompli. As we have seen in the past, successful innova-
tions are often those which pay more attention to market demand than to 
technological opportunity.
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A product or service must be relevant, have demonstrated value and 
meet specific needs in order to prosper. Therefore, the ultimate objective of 
any commercial research and development program should be to secure a 
better match between the production of resources and their utilization by in-
dustry and consumers. As eluded to earlier, public reaction will be vital in 
determining overall market impacts of animal biotechnology. Consequently, 
greater effort must be focused toward cost-reducing and environmentally 
friendly innovations. While there are many promising applications of bio-
technology on the horizon, biotechnology is neither a panacea nor a com-
plete replacement for established tools. It provides an additional approach to 
agricultural problems.
Recent studies have shown, among other things, that emerging products 
of biotechnology will require considerable management expertise on the part 
of producers (National Research Council, 1990; Office of Technology Assess-
ment, 199Id; Van der Wal et al., 1991). As with many other technological ad-
vances, the farmers that will benefit most will be the more efficient managers 
and early adopters. Furthermore, price support programs, marketing orders, 
grading systems and regulatory mechanisms will all need to adapt to 
tomorrow’s dynamic production systems.
L O O K I N G  T O  T H E  F U T U R E
Leadership in technology development and utilization is the role the U.S. 
has, can, and seeks to assert for the rest of the world. As noted earlier, the 
U.S. federal investment in biological research of the past 30 years has laid the 
foundation for a strong biotechnology enterprise. Because the field is moving 
rapidly, historical leadership does not ensure continued superiority (Federal 
Coordinating Council for Science, Engineering, and Technology, 1992).
Looking toward the future, what elements could present a positive sum 
strategy for animal biotechnology in the 1990s? What will be the challenges 
that influence animal agriculture in the years to come?
First of all, a sound national strategy for biotechnology in agriculture 
must focus on solving pivotal scientific and agricultural problems, effectively 
utilizing the funds and institutional structures available to support research, 
training researchers in advanced scientific areas, and efficiently transferring 
technology (National Research Council, 1987). Both industry and govern-
ment have appropriate roles to play in this process (Council on Competitive-
ness, 1991). There is a need to construct institutional infrastructures that fa-
cilitate more effective collaboration among animal scientists, engineers, 
agronomists and health scientists to deal with issues of production, environ-
mental change and the health of producers and consumers (Ruttan, 1991).
The Cooperative Extension Service and educational institutions must 
keep pace with ongoing change to be relevant to the future competitiveness 
and profitability of American agriculture. Producers of the future will need,
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and desire, a new menu of technologies that recognize contemporary goals 
such as enhanced profitability, increased environmental stewardship, rural 
revitalization and development, and global competitiveness (National Re-
search Council, 1987). Further, there is a need to increase the involvement of 
farmers, researchers and allied industry in developmental partnerships. 
These challenges will demand a correspondingly higher level of vision and 
sophistication on the part of government policymakers, regulators and in-
dustry leaders.
Crucial to all the various points discussed previously is the effectiveness 
of our world trading system. A global approach to the regulation and accept-
ability aspects of biotechnology is worth pursuing in order to create an im-
proved atmosphere of mutual confidence between producers, manufacturers 
and consumers. Moreover, the removal of nontariff trade barriers between 
the world’s trading partners and the development of a common reference 
point is of vital importance while at the same time providing the flexibility to 
accommodate unforeseen and justifiably unique national considerations.
C O N C L U S I O N S
World agriculture stands at the threshold of new scientific and technical de-
velopments in animal science, biology, chemistry, genetics, agricultural engi-
neering, information technology and many other fields. In most of the world, 
the transition from a resource-based to a science-based system of agriculture 
is occurring within a single century (Ruttan, 1991).
Emerging technologies, industry economics and public policy will play 
critical roles in shaping U.S. animal agriculture in the decade of the 1990s. 
Advances in health maintenance, reproduction efficiency and information 
technology will all affect the industry. Additional research is needed to gain 
an increased understanding of the factors influencing animal growth, envi-
ronmental adaptation and well-being, and disease resistance (National Re-
search Council, 1989).
Legislative and regulatory activities that occur in Washington are having 
a greater effect on animal agriculture each year. A simple statement of need is 
no longer enough to justify the allocation of funds for new programs, new fa-
cilities or new research efforts (Waggoner et al., 1989). Consultancies, affili-
ate programs, consortia, research parks and other forms of partnership be-
tween the public and private sectors that foster communication and technol-
ogy transfer should be promoted (National Research Council, 1987).
Certainly, we must not overlook or push aside the legitimate concerns of 
the public and work to establish those principles which govern the safe envi-
ronmental use of emerging products. In such a fast-moving technological 
environment, it will be necessary to regularly review the appropriateness of 
the scientific basis of existing regulation and to make any required adjust-
ments in either the technology or the statutory framework.
Public Policy in the 1990s
There are, of course, numerous scientific and technological bottlenecks 
and data gaps that still have to be overcome, as can be expected of a technol-
ogy that has been expanding so swiftly and in so many directions. Granted, 
the outcome of the best science can be unpredictable. The obstacles to craft-
ing an effective strategy to support competitiveness in animal biotechnology 
are formidable. However, the potential payoffs are abounding.
The genius that has driven America’s prosperity throughout its history 
has been the ability to combine collective vision with diversity and individu-
alism—to unite grand ideals with arduous pragmatism. As U.S. agriculture 
enters the 21st century, this genius will be put to its most strident test.
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